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In this work, we compared the profile of proteins secreted by planktonic and biofilm cultures of Pseudomonas aeruginosa using
two-dimensional difference gel electrophoresis (2D-DiGE). This revealed that a novel metzincin protease, Mep72, was secreted
during biofilm growth. SubsequentWestern blotting and reverse transcription-PCR (RT-PCR) analyses demonstrated that
Mep72 was expressed only during biofilm growth. Mep72 has a tridomain structure comprised of a metzincin protease-like do-
main and two tandem carbohydrate-binding domains. Unlike the only other metzincin (alkaline protease; AprA) in P. aerugi-
nosa, Mep72 is secreted through the type II pathway and undergoes processing during export. During this processing, the metz-
incin domain is liberated from the carbohydrate-binding domains. This processing may be self-catalyzed, since purifiedMep72
autodegraded in vitro. This autodegradation was retarded in the presence of alginate (an extracellular matrix component of
many P. aeruginosa biofilms). The expression of full-lengthmep72 in Escherichia coli was toxic. However, this toxicity could be
alleviated by coexpression ofmep72with the adjacent gene, bamI. Mep72 and BamI were found to form a protein-protein com-
plex in vitro. 2D-DiGE revealed that the electrophoretic mobility of several discrete protein spots was altered in the biofilm se-
cretome of anmep72mutant, including type III secretion proteins (PopD, PcrV, and ExoS) and a flagellum-associated protein
(FliD). Mep72 was found to bind directly to ExoS and PcrV and to affect the processing of these proteins in the biofilm secre-
tome.We conclude that Mep72 is a secreted biofilm-specific regulator that affects the processing of a very specific subset of viru-
lence factors.
Pseudomonas aeruginosa is an opportunistic human pathogenand a major cause of chronic infections in individuals with
cystic fibrosis (CF). Chronic P. aeruginosa infections have long
been associated with a biofilm mode of growth, characterized by
the formation of sessile microbial communities and the produc-
tion of exopolysaccharide (1–4). Such infections are particularly
difficult to eliminate due to reduced immune clearance and their
high tolerance to antibiotic treatment (5, 6). However, the biofilm
phenotype remains poorly defined. A number of proteomic and
transcriptomic analyses have been employed to investigate the
lifestyle changes associated with the transition from a planktonic
growth mode to a biofilm growth mode (7–12). In spite of this,
there remains little consensus on what defines a biofilm (13).
P. aeruginosa is also a secretor. Secreted virulence factors are
partly responsible for causing the extensive tissue damage associ-
ated with P. aeruginosa acute infections (14). Proteinaceous viru-
lence factors are exported through the numerous secretion sys-
tems encoded by the P. aeruginosa genome (15). Many of these
secreted proteins are hydrolytic enzymes which include the type
I-secreted alkaline protease, AprA, and various type II-secreted
proteases, such as elastase (LasB), staphylolysin (LasA), and PvdS-
regulated protease (PrpL). Other virulence determinants are se-
creted through the type III secretion system (T3SS). The T3SS has
been proposed to inject effector proteins directly into the host cell
(16, 17). The expression of the T3SS often correlates with severe
disease and increased mortality (18, 19).
A pair of two-component sensor systems have been identified
that reciprocally regulate T3SS expression and biofilm formation
(20, 21). As a result, biofilm cells often are thought of as being less
virulent than planktonic cells, and the formation of biofilms is
thought to represent a commitment toward chronic infection
(22). However, biofilms also have been associated with acute in-
fections (23), and chronic infections do not necessarily involve
biofilm formation (24). Moreover, the expression of T3S proteins
has been detected in biofilms grown under certain conditions,
suggesting that biofilm formation and T3S are not always neces-
sarily mutually exclusive phenotypes (11, 25).
To the best of our knowledge, only a few studies have investi-
gated whether specific secreted proteins are associated with the
biofilmgrowthmode. Todate,most previous studies have focused
on the production of secreted proteins by planktonic cultures (26–
29). However, one study by Toyofuku and colleagues examined
the secreted proteins that associated with the extracellular poly-
saccharide matrix. These workers demonstrated that outer mem-
brane vesicles commonly associatewith the biofilmmatrix, imply-
ing that these vesicles are core constituents of P. aeruginosa
biofilms (30). Another study showed that three extracellular pro-
teases (AprA, LasB, and PrpL) were upregulated by Ca2 in a
mucoid P. aeruginosa strain (FRD1) grown under continuous-
flow conditions (31). These proteases were upregulated concom-
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itantly with the alginate biosynthetic gene, algD, in the presence of
high levels of Ca2 in the culture medium. A study by Purschke
and colleagues compared the secretomes of P. aeruginosa and
Candida albicans inmixed biofilms (32). Here, they demonstrated
that the diversity of P. aeruginosa proteins secreted in mixed-cul-
ture conditions was lower than in single-culture conditions. How-
ever, some secreted proteins (such as the virulence factor ToxA
and hemophore HasAp) were uniquely expressed in mixed bio-
films but were not detected in monocultures. Furthermore, pro-
teinaceous factors, such as the adhesin CdrA, have been shown to
be upregulated under biofilm conditions (33). CdrA is thought to
contribute to biofilm structural integrity by either cross-linking
Psl polysaccharide and/or by tethering Psl to cells.
Recently, Balyimez et al. reported that the transcription of two
uncharacterized P. aeruginosa open reading frames (ORFs),
PA2782 and PA2783, is under the control of the cyclic AMP
(cAMP)-responsive transcriptional regulator, Vfr, and that Esch-
erichia coli cells expressing PA2783 displayed proteolytic activity
(34). They subsequently renamed PA2783 as Mep72, after the
family of metalloendopeptidases to which the protein belongs. In
this work, we show that Mep72 is in fact a biofilm-associated se-
creted protein. We also show that Mep72 binds to the product of
its coregulated adjacent gene, PA2782, and that this interaction
reduces the toxicity of Mep72 when expressed in E. coli cells. We
also demonstrate that Mep72 autocatalytically degrades in vitro
and is processed in vivo. Finally, we demonstrate that Mep72 ex-
pression in biofilms specifically affects proteins exported by the
type III secretion machinery.
MATERIALS AND METHODS
Strains andgrowth conditions.Bacterial strains andplasmids used in this
study are listed in Table S1 in the supplemental material. P. aeruginosa
cultures were grown at 37°C in AGSY medium (56 mM alanine, 17 mM
K2HPO4, 86 mM NaCl, 100 M CaCl2, 10 mM MgSO4, 5 M FeCl2, 7.5
MZnCl2, 0.5% [vol/vol] glycerol, 3 g/liter yeast extract, pH 7). P. aerugi-
nosa forms robust biofilms in AGSY medium, and transcriptomic/pro-
teomic data are available (11, 35). Planktonic cultureswere grown inflasks
with vigorous shaking and harvested after 3 h (late exponential phase;
optical density at 600 nm [OD600],1) or 9 h (stationary phase; OD600,
9). Continuous-flow biofilms were grown in AGSY medium as previ-
ously described by Mikkelsen et al. (35).
E. coli cells were grown in Luria broth (LB) or on LB agar (1.5%
[wt/vol] Bacto agar) plates.
Carbenicillin was used at final concentrations of 200 g ml1 for P.
aeruginosa and 50 g ml1 for E. coli. Isopropyl--D-thiogalactopyrano-
side (IPTG) was used at a final concentration of 0.3 mM for the induction
of protein expression.
Plasmid construction. PAO1 genomic DNA was used as a template
for PCR-based amplification of the bamI (for biofilm-associated metzin-
cin inhibitor and mep72 ORFs. The primers are listed in Table S2 in the
supplemental material. The maltose-binding protein (MBP)–Mep72 ex-
pression plasmid [pMal-P2X(mep72)] was constructed by introducing
the PCR-amplifiedmep72ORF (minus the first 20 amino acid residues,
which encode the endogenous signal sequence) into the EcoRI and
HindIII sites of pMal-P2X. The BamI-MBP-Mep72 expression plasmid
[pMal-P2X(bamI,mep72)] was constructed by introducing the PCR-am-
plified bamIORF into the NdeI site of pMal-P2X(mep72). TheHis6-BamI
expression plasmid [pQE80(bamI)] was constructed by introducing the
PCR-amplified bamI ORF into the BamHI and HindIII sites of pQE80.
The metzincin domain and carbohydrate-binding domain truncates
[pMal-P2X(mep72-Met) and pMal-P2X(mep72-CBM)]were constructed
by introducing the respective PCR-amplified domains of the mep72 ORF
into the EcoRI and HindIII sites of pMal-P2X. All cloned inserts were
verified by sequencing.
Protein extraction. Planktonic cell cultures were sedimented by cen-
trifugation (3,200 g, 30min, 4°C). Biofilm effluent was collected on ice,
andplanktonic cells were removedby centrifugation. The average number
of planktonic cells in the effluents before clarificationwas 2 107CFU/ml
(in comparison, planktonic cultures in stationary phase had an average
cell density of 2 1010 CFU/ml). The mean protein concentration in the
1-day biofilm effluents was 0.94 0.30g/ml. In comparison, the plank-
tonic stationary-phase (PS) samples contained 2.32 0.79g/ml protein.
Supernatants from the biofilm and planktonic cultures were passed
through a 0.2-m filter (Millipore), and protein was precipitated by the
addition of solid trichloroacetic acid to a final concentration of 12.5%
(wt/vol). Protein was left to precipitate overnight at 4°C and was collected
by sedimentation (3,200  g, 30 min, 4°C). Pellets were washed three
times in 50% ethanol and redissolved in 3-[(3-cholamidopropyl)-di-
methylammonio]-1-propanesulfonate (CHAPS) buffer (6 M urea, 2 M
thiourea, 10 mM Tris, 4% CHAPS detergent, pH 8.5). Intracellular pro-
teins (for Western blotting) were prepared by normalizing cell pellets to
the same optical density (OD600) using TE buffer (50 mM Tris, 4 mM
EDTA, pH 8.3) and sonication on ice. Cell debris was removed by centri-
fugation (3,200 g, 30 min, 4°C).
Proteomic analysis. Samples were harvested and prepared for pro-
teomic analysis essentially as described by Mikkelsen et al. (35), with mi-
nor modifications. Briefly, for the growth-mode secretome comparison,
four biological replicates were analyzed for each growth condition. Plank-
tonic cells and biofilms of P. aeruginosa PAO1 were grown in AGSY me-
diumas previously described (35). Planktonic cells were harvested in early
stationary phase. Biofilms were grown in a continuous flow system (35),
and extracellular proteins were harvested for proteomic analysis after 24 h
by collecting ca. 150 ml of the tube effluent directly into a flask packed in
ice. Culture supernatants were clarified by centrifugation (8,000 g) and
filtration (0.2-m filter; Millipore Stericup). Proteins were precipitated
by addition of trichloroacetic acid (10%, wt/vol, final concentration) and
harvested by centrifugation (100,000  g, 4°C, 45 min). Pellets were
washedwith 50% ethanol and resuspended in ASB14 buffer (35). Samples
were analyzed by two-dimensional difference gel electrophoresis (2D-
DiGE), and statistical analysis was performed using BVA (biological vari-
ance analysis) and HCA (hierarchical cluster analysis) as previously de-
scribed (35). Master numbers were assigned by the DeCyder software and
refer to the position of the protein spot on the master gel. For the pro-
teomic comparison of the mep72 mutant and wild-type secretome, a sin-
gle biological sample was analyzed using dye-swapped technical repli-
cates, and themodulated protein spots were identified as described above.
For the comparison of the mep72 mutant and wild-type secretome, pro-
tein spots were selected for mass spectrometry analysis based on whether
they were present in one sample and absent from the other, as opposed to
protein spots that were modulated between samples. The samples were
analyzed by 2D-DiGE, and statistical analysis was performed using bio-
logical variance analysis and hierarchical cluster analysis. Protein spots
were excised and digested for liquid chromatography-tandemmass spec-
trometry (LC-MS/MS) analysis, and the output data were used to search
the Pseudomonas aeruginosa database usingMASCOT. Protein identifica-
tions were considered significant only if theMASCOT score was	80 and
they contained one or more peptides with an E value of
0.01. Hits com-
prising more than one protein identification were discarded from further
analysis.
Western blot analysis. The protein concentration in samples was
quantified spectrophotometrically using Bradford reagent (Sigma). Equal
amounts of protein from cell-associated and secreted fractions were sep-
arated on 12% sodiumdodecyl sulfate-polyacrylamide gels, transferred to
polyvinylidene fluoride membranes, and analyzed by Western blotting.
ExoS and PcrV primary antibodies were a gift from Arne Rietsch, Case
Western Reserve University. Polyclonal anti-Mep72 primary antibody
was prepared from rabbits that had been immunized with a peptide cor-
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responding to residues CGIGYMGSGDKNSGR of the metzincin domain
(residues 126 to 140) of Mep72. Immunization and antibody preparation
was carried out by BioGenes (Germany). Anti-His6 primary antibody was
purchased from Cell Signaling Technology. Enhanced chemilumines-
cence peroxidase-labeled anti-rabbit IgG antibodies (Sigma) were used as
secondary antibodies. Blots were developed using Immobilon Western
chemiluminescent horseradish peroxidase (HRP) substrate (Millipore).
Protein refolding. Inclusion bodies of His6-Mep72 were harvested
and solubilized in 50 mM Tris-HCl (pH 8) containing 300 mMNaCl, 15
mM imidazole, and 8 M urea. The solubilized protein solution was clari-
fied by centrifugation (9,000 g, 30 min, 20°C) and loaded onto a 2-ml
(packed bed volume) nickel-nitrilotriacetic acid (Ni-NTA) column equil-
ibrated in the same buffer. The column was loaded and washed at room
temperature. The column was washed with ca. 200 ml equilibration buf-
fer. Elution was done by increasing the imidazole concentration to 300
mM. For refolding, the eluted protein was rapidly diluted into a 20-fold
volumetric excess of 50 mM Tris-HCl (pH 8) containing 200 mM NaCl.
Where indicated, the refolding buffer was supplemented with sugars or
polymers.
MBP-tagged Mep72 was purified in a similar way. Inclusion bodies
were harvested and solubilized in 8 M urea. The sample then was rapidly
diluted by squirting it into a large volumetric excess of rapidly stirred
refolding/column buffer (20 mM Tris-HCl [pH 7.4] containing 200 mM
NaCl and 1 mM EDTA) at 4°C. After 60 min, the sample was clarified by
centrifugation and the soluble supernatant was loaded directly onto an
amylose affinity resin. The column was washed overnight, and the bound
protein was eluted in column buffer containing 10 mM maltose. Eluted
fractions were pooled and concentrated by ultrafiltration (10,000 molec-
ular weight cutoff; Millipore) in a centrifugal concentrator.
Immunoprecipitation (pulldown). His6-BamI and MBP-Mep72
were expressed in E. coli DH5 from pQE80(bamI) and pMal-P2X
(mep72), respectively, in 1 liter of LB. Cells were grown with vigorous
shaking at 37°C to mid-log phase, after which protein expression was
induced by the addition of IPTG to a final concentration of 0.3 mM. Cells
subsequently were grown at 25°C overnight with shaking. Cells were sedi-
mented by centrifugation (4,000  g, 20 min, 4°C), and the pellets were
resuspended in buffer A (50 mM Tris, 200 mM NaCl, pH 8.0). The cells
were lysed by sonication on ice. Both recombinant proteins formed insol-
uble inclusion bodies. The inclusion bodies were collected by sedimenta-
tion (9,000 g, 30 min, 4°C) and solubilized in buffer A containing 8 M
urea. Insoluble material was removed by centrifugation (9,000  g, 30
min), and the proteins were refolded by rapid injection into a 16-fold
volumetric excess of rapidly stirred buffer A. The dilute bait protein sus-
pensions thenwere loaded onto the appropriate affinitymatrix (Ni-NTA–
agarose [Qiagen] to capture theHis-tagged BamI and amylose resin [New
England BioLabs] to capture theMBP-taggedMep72). The columns then
were washed to remove unbound bait protein before applying the target
protein solution. (As a control, the target protein solutions also were run
through Ni-NTA or amylose columns to which no bait protein had been
preadsorbed.) After washing the columns to remove unbound target pro-
teins, the bound proteins were eluted with either 300 mM imidazole (for
the Ni-NTA affinity matrix) or 10 mM maltose (for the amylose affinity
matrix).
For the ExoS and PcrV pulldown, P. aeruginosa planktonic cultures
(eight 25-ml cultures) were grown to stationary phase, and the culture
supernatants were passed through a 0.2-m filter (Millipore). Secreted
proteins were concentrated in a 10-kDa cutoff centrifugal concentrator
(Millipore) to a final volume of 1 ml (3,200 g, 4°C). The concentrated
protein was diluted 20-fold in buffer A before being loaded onto the af-
finity capture matrix.
qRT-PCR. All cells were harvested directly into RNAlater (Am-
bion), kept at 4°C overnight, and stored at 80°C until use. The cul-
ture-RNAlater mixture was thawed on ice, and a suitable amount of cells
was sedimented by centrifugation. Cells were resuspended in water con-
taining 1 mg lysozyme ml1 (Sigma) and incubated for 15 min at room
temperature. RNA was extracted using an RNeasy Mini purification kit
(Qiagen) by following the manufacturer’s instructions. The resulting
RNA (200 ng) was used as a template for reverse transcription and con-
version into cDNA using Superscript II reverse transcriptase (Invitrogen)
by following the manufacturer’s instructions. Quantitative real-time re-
verse-transcription PCR (qRT-PCR) was performed on the cDNA using
1 SYBR green PCR master mix (Applied Biosystems) with 10 pmol of
the appropriate primers (see Table S2 in the supplemental material). Am-
plification was carried out using an ABI PRISM 7300 real-time PCR sys-
tem, and fluorescence data were processed using SDS software (ABI).
Relative gene expressionwas obtained using 16S rRNAas the control, with
mRNA/16S rRNA from each sample set equal to 1. Three biological rep-
licates were examined for each growth condition.
RESULTS
Biofilmandplanktonic secretome comparisonby 2D-DiGE.We
wanted to test directly whether biofilms of P. aeruginosa secrete an
altered spectrum of proteins compared with planktonic cells.
Continuous-flow biofilms were grown in silicon tubing as previ-
ously described (35), and secreted proteins were harvested. The
secretome obtained from PAO1 biofilms grown for 1 day (1dB)
was compared with that harvested from a stationary-phase plank-
tonic culture of PAO1 (PS). The secretome samples were analyzed
by quantitative 2D-DiGE (Fig. 1). One hundred sixteen spots were
modulated in the biofilm samples (93 upregulated, 13 downregu-
lated; P  0.01). A selection of the most highly modulated spots
were excised from the gels and identified by LC-MS/MS and
MASCOT searching of the P. aeruginosa database (Table 1). Sev-
eral spots corresponding to known virulence factors were upregu-
lated in the biofilm secretome, including LasA, PasP, and PcrV.
Additional upregulated spots corresponded to SpuE, AotJ,
PA1342, and PotF5, all of which are predicted to be involved in
polyamine uptake. Polyamines have been shown to play a role in
the tolerance of P. aeruginosa to some antibiotics (36–38), al-
though the mechanism underlying this currently is unknown.
Other upregulated proteins included the ferric iron receptor
FIG 1 Proteomic analysis of the biofilm and planktonic cell secretome frac-
tion. The fluorescence image of a Cy2-labeled pooled internal standard is
shown. A selection of the protein spots that were identified by LC-MS/MS are
indicated.
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(HitA; perhaps indicative of a shortage of ferric iron in the bio-
film), the sulfate binding protein of the sulfate ABC uptake system
(CysP), and a PvdS-regulated protease (PrpL). PvdS is an alterna-
tive sigma factor that stimulates the expression of a siderophore
(pyoverdine) as well as other genes (e.g., prpL [39]), again indicat-
ing iron limitation in the biofilm. Finally, we observed several
spots corresponding to the chitin-binding domain protein CbpD,
previously known as LasD. Two of the CbpD spots were less abun-
dant in the biofilm secretome and one was more abundant. CbpD
is known to be processed by other secreted proteases (40), and we
suspect that this explains the concomitant appearance of appar-
ently up- and downregulated spots.
An uncharacterized protein, PA5033, also was upregulated in
the biofilm secretome. PA5033 is predicted to form a bicistronic
operon with the adjacent gene, PA5032 (41). PA5032 is predicted
to encode an AraC-like transcriptional regulator. The PA5032-
PA5033 cluster is found only in P. aeruginosa and not in any other
sequenced Pseudomonas spp., suggesting that these genes are spe-
cifically important for the lifestyle of P. aeruginosa. Bioinformatic
analysis of the PA5033 amino acid sequence revealed that it is
comprised of 6 or 7 consecutive blocks of repeated sequence, rem-
iniscent of the -propeller structure associated with FG-GAP-
containing proteins, integrins, and adhesins (42, 43). However, a
profile screen (MOTIF, KEGG2) of the repeated unit revealed no
significant matches in the Swiss-Prot database.
We also noted that PA2783 (Mep72) was 18-fold upregulated
in the biofilm secretome.mep72 is predicted to form a bicistronic
operon with its adjacent gene, PA2782 (Fig. 2A). To test this, we
harvested RNA from PAO1 biofilms. The RNA was converted to
cDNA and used as a template to PCR amplify across the junction
between PA2782 andmep72 using primers P1 and P2 (Fig. 2B). If
the genes are transcribed as a single contiguous transcript, a
500-bp product would be anticipated, and this is what was ob-
served (Fig. 2B). No 500-bp product was observed in the no-RT
control. We obtained no evidence that PA2782 is cotranscribed
with the upstream gene (PA2781) or that mep72 is cotranscribed
with the downstream gene (PA2784) (data not shown).
Pfam domain analysis of Mep72 revealed that the protein is
comprised of three domains: an N-terminal metalloprotease do-
main and two tandem C-terminal carbohydrates (Fig. 2C). The
amino acid sequence of the N-terminal domain was analyzed
using the sequence-structure homology recognition program
FUGUE (44). This analysis suggested that Mep72 is structurally
related to snake venom metalloproteases (adamalysins) and
snake venom endothelial cell vascular apoptosis-inducing pro-
tein (VAP-1), which aremembers of themetzincin superfamily of
zinc-dependent metalloproteases (45, 46). Further inspection of
the primary structure of Mep72 revealed that it contained both
of the conserved sequence motifs (the zinc-binding motif and
Met-turn) characteristic of metzincins (46). The bacterial metz-
incins, also known as serralysins, often are associated with viru-
lence. Indeed, the only other metzincin encoded by the PAO1
TABLE 1 Summary of the identified protein spots modulated in the biofilm-grown culture secretome compared with their activity in the planktonic
culture secretome
Function and PA no. Master no. Gene name Gene product
Level of
abundancea
Modulated ratiob
(biofilm/PS)
Transport of small molecules
PA0301 1022 spuE Polyamine transport protein 1 19.8
1033 1 10.0
971 1 13.6
PA4687 996 hitA Ferric iron-binding periplasmic protein HitA 1 17.5
PA2592 1019 potF5 Probable periplasmic spermidine/putrescine-binding
protein
1 33.9
PA1493 960 cysP Sulfate-binding protein of ABC transporter 1 6.4
PA0888 1469 aotJ Arginine/ornithine binding protein AotJ 1 17.9
1480 1 14.1
PA1342 1155 Probable lysine/arginine/ornithine-binding protein 1 9.9
Known virulence factors
PA0423 1765 pasP P. aeruginosa small protease PASP 1 5.2
PA1871 1687 lasA LasA precursor 1 16.5
PA4175 663 prpL PvdS-regulated endoprotease, protease IV 1 39.1
PA1706 1404 pcrV Type III secretion protein PcrV 1 17.6
PA0852 1170 cbpD Chitin-binding protein CbpD precursor 1 8.0
1844 2 37.9
1830 2 85.3
Unclassified hypothetical proteins
PA5033 1300 Hypothetical protein PA5033 1 15.5
PA2783 1313 mep72 Hypothetical protein PA2783 1 18.1
Central intermediary metabolism: 1721 ppa Inorganic pyrophosphatase 2 3.9
PA4031 1713 2 3.4
a1 and2 indicate whether the spot was more or less abundant, respectively, in the biofilm secretome than in the planktonic secretome.
b Modulated ratio represents the fold change in the biofilm secretome compared to that in the planktonic secretome.
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genome is the well-established virulence factor AprA (alkaline
protease). Unlike AprA, which has a dedicated type I secretion
system,Mep72 has anN-terminal signal sequence and is predicted
to be targeted to the periplasm via the Sec pathway. Analysis of the
amino acid sequence of the C-terminal domains suggests that they
are members of the carbohydrate-binding module (CBM) family,
usually found in proteins that degrade or bind to polysaccharides
(47). The remainder of this study investigates the function and
properties of this biofilm-associated metzincin protease. Addi-
tionally, we investigate the relationship between mep72 and its
adjacent gene (PA2782), which we designate bamI (for biofilm-
associated metzincin Inhibitor).
Expression ofMep72 is upregulated in continuous-flow bio-
films. In order to determine the transcriptional expression profile
ofmep72, qRT-PCR was carried out on RNA harvested from bio-
film cells (1dB) grown in a continuous-flow setup and from cul-
tures of planktonic cells (Fig. 3A shows the data for exponentially
growing planktonic cultures [PE]; essentially the same results
were obtained for comparisons of stationary-phase planktonic
cultures with biofilm cells [data not shown]). mep72 transcript
levels were 18-fold upregulated in 1dB cells compared with the
level for planktonic cells, corroborating the observations from the
2D-DiGE analysis. The expression profile of bamI also was as-
sessed by qRT-PCR (Fig. 3A). This revealed that the expression of
bamI follows that of mep72 and was upregulated in continuous-
flow biofilms, and that bamI was poorly expressed in planktonic
cells. This is consistent with the notion that bamI and mep72 are
functionally linked.
To further verify that Mep72 expression is biofilm specific,
secreted proteins from biofilm and planktonic cultures were ex-
tracted, and the expression of Mep72 was monitored by Western
blotting with an antibody raised to the metzincin domain of
Mep72 (Fig. 3B). Mep72 was undetectable in the secretome of
aerobically grown PE and PS planktonic cultures but was abun-
dant in continuous-flow biofilm supernatants. NoMep72 was de-
tected in the biofilm secretome of an mep72 mutant (Fig. 3B).
These transcriptomic and proteomic analyses indicate thatMep72
is a biofilm-associated gene product under these growth condi-
tions.
Mep72 is secreted via the type II secretion system and is pro-
cessed during export. SinceMep72 is secreted to the extracellular
milieu and has a predicted N-terminal Sec secretion signal, it is
likely to be exported via the type II general secretory pathway
(GSP). Therefore, we predicted that Mep72 would serve as a sub-
strate for the Xcp system, the main terminal branch of the GSP in
P. aeruginosa (48). To test this, cell-associated and secreted pro-
teins were harvested from biofilms of PAO1 and an xcpP-Zmu-
tant and compared by immunoblot analysis (Fig. 4). Comparison
of the cell-associated fractions demonstrates that full-length
Mep72 (65 kDa) is expressed in both strains. However, compari-
son of the secreted fraction reveals that while Mep72 is detectable
in the biofilm secretome of PAO1, it is absent from the secretome
of an xcpP-Z mutant. This suggests that Mep72 is indeed se-
creted through the Xcp pathway. The data presented in Fig. 4 also
show that Mep72 undergoes processing during or following its
export. The cell-associated protein product corresponds to the
predicted full-length isoform (metzincin domain plus tandem
FIG 2 Bioinformatic analyses of PA2783 (Mep72). (A) Genomic context of
bamI (PA2782) andmep72. Schematic locations of the primers used to confirm
the operonic organization of bamI andmep72 are indicated. (B) cDNA (RT)
from biofilms was used as a template for PCR with the primers indicated in
panel A to amplify the intergenic region between bamI and mep72. A reaction
without reverse transcriptase (RT) was carried out as a control. (C) Pre-
dicted domain structure of the metzincin Mep72. Numbers correspond to the
amino acid residues comprising each domain and the predicted secretion sig-
nal sequence (Sig seq). The full-length protein is 599 residues long.
FIG 3 mep72 expression in biofilms and planktonic cultures. (A) qRT-PCR
analysis of mep72 and bamI transcript levels in cells sampled from planktonic
exponential-phase (PE) and 1-day-old continuous-flow biofilms (1dB). Sim-
ilar results were obtained in comparisons of 1dB biofilm-grown cells with
planktonic stationary-phase cultures. The error bars represent standard devi-
ations from 3 replicates. (B) Western blot analysis of Mep72 expression and
secretion in PE, planktonic stationary-phase (PS), and continuous-flow bio-
films of the wild-type (PAO1) and the mep72 mutant.
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carbohydrate-binding domains) with amolecularmass of 65 kDa.
However, the secreted protein product has a lowermolecularmass
(25 kDa) and, given its size and reactivity with the antibody
(which was raised against a sequence of amino acids in the metz-
incin domain), most likely corresponds to the metzincin domain
only. The same 25-kDa processed form was observed in the bio-
film secretome ofmutants containing disruptions in genes encod-
ing the major P. aeruginosa secreted proteases (LasA, LasB, AprA,
and PrpL) (data not shown), suggesting that the protein is pro-
cessed by a minor protease or that it undergoes autoprocessing.
Autoprocessing is not uncommon for members of the metzincin
protease superfamily. Metzincin proteases often are translated as
inactive precursor peptides which subsequently undergo an auto-
processing event that yields their enzymatically active, mature
form (46).
Ectopic expression of Mep72 in E. coli is toxic. To further
investigate the properties of Mep72, we recombinantly expressed
the gene in E. coliDH5. An N-terminal maltose-binding protein
(MBP) with Sec leader peptide was fused to the mature portion
(residues 21 to 599) of the mep72 ORF and expressed from an
IPTG-inducible promoter. Upon inductionwith IPTG, a decrease
in cell viability was observed (Fig. 5A). This reduction in cell via-
bility suggests that recombinant Mep72 expression is toxic to the
cell. We speculated that the product of the cotranscribed bamI
gene functions to counteract this effect. To test this, bamI was
cloned upstream of the MBP-Mep72 fusion protein. In this con-
struct, both genes (bamI and mep72) were expressed from the
same IPTG-inducible promoter. Upon induction with IPTG, cell
viability was restored to the level of the plasmid-only control (Fig.
5A). This suggests that BamI is essential for counteracting the
toxic effect(s) of Mep72. This is reminiscent of the situation en-
countered with the alkaline protease, AprA, and its cognate inhib-
itor protein, AprI (49–51). Although the exactmechanism of AprI
action remains unclear, it has been proposed that AprI binds to
AprA, preventing premature protease activity until the protein has
been secreted.
Mep72 and BamI physically interact in vitro. To determine
whether the countertoxic effect of BamI on Mep72 was mediated
through a physical interaction between the two proteins, a pull-
down assay was carried out. Briefly, BamI containing an N-termi-
nal hexahistidine tag (His6-BamI) was expressed in E. coli, re-
folded in vitro, and immobilized on anNi-NTA affinity matrix. In
a separate culture, MBP-Mep72 was expressed, refolded in vitro,
and then passed through either a clean Ni-NTA affinity matrix
(control resin) or through the Ni-NTA matrix to which His6-
BamI had been attached. The columns were washed, following
which the bound proteins were eluted and resolved by SDS-
PAGE/Western blotting (Fig. 5B). MBP-Mep72 (105 kDa) bound
to the column that was precharged with His6-BamI but did not
bind theNi-NTA affinitymatrix in the absence ofHis6-BamI. This
demonstrates that BamI andMep72 do indeed physically interact
in vitro and suggests that the countertoxic effect of BamI on
Mep72 is mediated through formation of a protein-protein com-
plex. It should be noted that since both the BamI and Mep72
protein preparations were necessarily obtained by refolding in
vitro (these proteins partition into insoluble inclusion bodies
when overexpressed in vivo), it is formally possible that only a
small fraction of the proteins were in their physiologically active
conformation. Therefore, the extent of coprecipitation observed
FIG 4 Western blot analysis of Mep72 secretion in biofilms of PAO1 and a
xcpP-Z mutant. Cell, cell-associated fraction; Sec, secreted fraction.
FIG 5 Ectopic expression of mep72 in E. coli is toxic but is counteracted by
coexpression of mep72 with bamI. (A) Serial dilutions of E. coli carrying plas-
mid-encoded, IPTG-inducible MBP-Mep72 [pMAL-p2X(mep72)], BamI-
MBP-Mep72 [pMAL-p2X(bamI,mep72)], and empty pMAL-p2X vector con-
trol (pMAL-p2X) were spotted onto LB-agar plates with and without IPTG.
The spotted dilutions were allowed to grow for 24 h before being photo-
graphed. (B) Mep72 forms an isolable complex with BamI. His6-BamI was
overexpressed in E. coli and refolded. The refolded protein was loaded onto an
Ni-NTA affinity matrix. The matrix was washed to remove any unbound
BamI. Following this washing, refolded MBP-Mep72 was passed over the ma-
trix. Excess MBP-Mep72 was washed off, and the bound proteins were eluted
in buffer containing 300 mM imidazole. The presence of BamI and Mep72 in
the column loadings and eluates was determined by Western blotting using
anti-His6 antibodies or anti-Mep72 antibodies, as indicated. As a control, we
measured the binding of MBP-Mep72 to Ni-NTA beads that had not been
pretreated with His6-BamI. Lane 1, eluate from column precharged with His6-
BamI after adding 300mM imidazole; lane 2, eluate from control column after
adding 300 mM imidazole.
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in Fig. 5B is likely to underrepresent the probable interaction in
vivo.
Mep72 has autoproteolytic activity. As with MBP-tagged
Mep72, overexpression ofHis6-taggedMep72 in liquid cultures of
E. coli caused the culture to stop growing, and the protein parti-
tioned into insoluble inclusion bodies. These inclusion bodies
were harvested, washed, denatured in 8M urea, and then refolded
by rapid dilution to yield the native protein.
PurifiedMep72 did not detectably proteolytically degrade gen-
eral substrates, such as azocasein, gelatin, or elastin, even after
prolonged incubation (data not shown). However, it did undergo
rapid autodegradation. As soon as theHis6-Mep72was renatured,
it began to autodigest (Fig. 6A). Autodigestion was essentially
complete after 60 min, with little evidence of partially digested
intermediates apparent. In contrast, MBP-tagged Mep72 re-
mained stable for hours, suggesting that the presence of the MBP
tag blocks autoproteolysis. To further test this possibility, we
treated the MBP-tagged Mep72 with factor Xa, which cleaves at
the junction between the two fused proteins. Once again, the lib-
erated Mep72 rapidly autodigested (data not shown). Interest-
ingly, the coliberated MBP tag apparently was unaffected by the
released Mep72, again indicating that the observed proteolysis is
highly specific. Taken together, these data suggest that recombi-
nant Mep72 is unstable due to autoproteolysis, at least under the
conditions prevailing after refolding.
Mep72 autoproteolysis is retarded by the presence of al-
ginate. Mep72 contains two C-terminal carbohydrate-binding
domains, raising the possibility that Mep72 binds polysaccha-
rides. Therefore, we wondered whether polysaccharides influence
Mep72 autoproteolysis. To investigate this, purified His6-Mep72
was renatured in the presence of various carbohydrates (including
monosaccharides, disaccharides, and polysaccharides), and the
subsequent autoproteolysis was monitored by SDS-PAGE (Fig.
6B). Incorporation of alginate into the refolding buffer clearly
FIG 6 Refolding, autoproteolysis, and toxicity of Mep72. (A) Shown is a Western blot of Mep72 undergoing autoproteolysis. Denatured His6-Mep72 was
refolded by rapidly diluting the urea denaturant. Samples were incubated for the indicated times before the addition of SDS sample buffer to stop any further
reaction. The products were resolved by SDS-PAGE and analyzed by Western blotting. An Mep72 sample incubated for 60 min in 8 M urea (i.e., maintained in
a denatured state) was used as a control. (B and C) Alginate retards Mep72 autoproteolysis. (B) Urea-denatured Mep72 was refolded as described for panel A,
except that the indicated sugars or sugar polymers were included in the refolding mixture. Reactions were allowed to proceed for 20 min before quenching with
SDS sample buffer and resolution by SDS-PAGE. The resultingCoomassie blue-stained gel is shown. The refolding buffers containedTris-HCl–NaCl alone (Tris)
or Tris-HCl–NaCl supplemented with 1% (wt/vol) alginate (Alg), glucose (Glu), arabinose (Ara), sucrose (Suc), maltose (Mal), polygalacturonic acid (PGA), or
cellulose (Cel), as indicated. (C) Kinetics of Mep72 autoproteolysis with or without 1% (wt/vol) alginate. His6-Mep72 was refolded as outlined above. Aliquots
of the refolded protein mixture were removed and quenched after a 2-, 10-, and 30-min reaction, as indicated. Shown is a Coomassie blue-stained gel of the
products. (D) Themetzincin domain and carbohydrate-binding domains ofMep72 are not themselves intrinsically toxic in the absence of BamI. Serial dilutions
of E. coli containing plasmid-encoded, IPTG-inducible N-terminal MBP fusions to the metzincin- and carbohydrate (CHO)-binding domains of Mep72 were
spotted onto LB-agar plates containing IPTG. The spotted dilutions were allowed to grow for 24 h before being photographed to record cell viability.
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retarded the rate of autoproteolysis compared with the other sug-
ars tested. These data indicate that the half-life of the protein can
be affected by factors that presumably bind to the carbohydrate-
binding domains. Further kinetic analyses confirmed that Mep72
autolysis is substantially delayed in the presence of 1% alginate
(Fig. 6C).
As shown in Fig. 5A, high-level expression of MBP-tagged
Mep72 is toxic to E. coli. However, we noted that prolonged (over-
night) incubation of induced liquid cultures of E. coli expressing
MBP-taggedmep72 sometimes led to a restoration in growth, pre-
sumably due to the outgrowth of less toxic spontaneous bypass
mutants.Western analyses revealed that inmost of thesemutants,
expression ofMep72was abolished (data not shown).However, in
one case (bypass mutant IP28), the mep72 ORF was found to
contain a C¡T transition, which led to the introduction of a stop
codon in place of Gln317. This mutation truncates the protein
downstream of the metzincin domain (residues 46 to 175) within
the first carbohydrate-binding domain (CBM domain; residues
302 to 427). Western blotting confirmed that IP28 expressed a
truncated, metzincin domain-containing protein. The location of
this truncation was surprising, since we had assumed that the
toxic effects of Mep72 expression in E. coli arose due to inap-
propriate proteolytic activity mediated by the metzincin do-
main, yet in IP28 the metzincin domain was intact. Therefore,
we examined whether the ectopic expression of the metzincin
domain alone or the tandem CBM domains was toxic to E. coli.
However, the expression of neither construct was toxic (Fig. 6D).
Taken together, these results suggest that the metzincin domain
and tandem CBM domains both are required for Mep72 toxicity
to bemanifest. However, this does not rule out the possibility that
the truncation of Mep72 resulted in improper folding, which
could account for the observed lack of toxicity.
Flagella and type III secretion factors are modulated in a
mep72 mutant. Given the results described above, we surmised
that Mep72 is not a general protease and that its target is highly
specific. To test whether specific pseudomonal proteins are af-
fected by Mep72 activity, we used 2D-DiGE to compare the pro-
teins secreted by a biofilm of PAO1 with those secreted by a bio-
filmof themep72mutant. The logic herewas that since proteolytic
processing often gives rise to a change in the electrophoretic mo-
bility of target proteins on 2D gels, spot shifts between the wild
type and mep72 mutant indicate that the corresponding proteins
are targets of Mep72 activity. Consistent with the notion that
Mep72 is not a general protease, the secretome of the mep72 mu-
tant overall was very similar to that of the wild type. However, a
small number of discrete changes in spot intensity were clearly
observed in the 2D gel electrophoretogram (see Fig. S1 in the
supplemental material).
Analysis of the spots more abundant in the PAO1 secretome
(Table 2) revealed three isoforms of Mep72, one with a high mo-
lecular weight (spot 880) and two more-abundant spots with
lower molecular weights (spots 1421 and 1426). The peptide se-
quences of the two lower-molecular-weight isoforms mapped
onto the metzincin domain only, while the peptide sequences of
the higher-molecular-weight isoformmapped onto themetzincin
domain and the first carbohydrate-binding domain of the protein.
These data are consistent with our earlier observation that Mep72
is likely to be processed during or shortly after secretion. Addi-
tional protein spots modulated in the PAO1 secretome included
the type III secretion translocation factor PcrV and the flagellum-
capping protein FliD.
Analysis of the protein spots that were more abundant in the
mep72 mutant secretome revealed additional type III secretion
factors. These included the T3SS translocation pore component
PopD and the effector proteins ExoS and, possibly, also ExoT
(ExoS and ExoT share very high levels of amino acid sequence
similarity). These data suggest that Mep72 targets certain secreted
T3S and flagellar proteins. Therefore, we postulated that there is a
direct physical interaction between Mep72 and the T3SS proteins
(see below).
To further confirm the DiGE results, we used Western blot
analysis to investigate whether PcrV and ExoS are differentially
processed in the biofilm secretome of the mep72 mutant com-
paredwith that in thewild type (Fig. 7A). Although ExoTmaywell
be targeted byMep72, since at least one spot (master no. 757) was
unambiguously assigned as ExoS and the other spot (master no.
751) was assigned as either ExoS or ExoT (due to the high level of
sequence similarity between the two proteins), we chose to focus
TABLE 2 Proteins modulated in PAO1 and mep72 secretomea
Function and PA no. Master no. Gene name Gene product
Level of
abundanceb
Fold
modulation
Spots displaying increased abundance in the wild-type
(PAO1) secretome
PA2783 1426 mep72 Metzincin protease Mep72 1 55.8
PA2783 1421 mep72 Metzincin protease Mep72 1 21.6
PA1706 1483 pcrV Type III secretion protein PcrV 1 7.9
PA1094 810 fliD Flagella capping protein FliD 1 7.6
PA2783 880 mep72 Metzincin protease Mep72 1 7.2
Spots displaying decreased abundance in the wild-type
(PAO1) secretome
PA1709 1401 popD Type III secretion protein PopD 2 7.1
PA3841 757 exoS Type III secretion effector ExoS 2 5.1
PA3841/PA0044 751 exoS-exoT Type III secretion effector ExoS/ExoT 2 3.8
a Summary of the identified protein spots modulated in the PAO1 secretome compared to their activity in the mep72 mutant secretome. While LC-MS/MS analysis identified spot
757 as ExoS, spot 751 was identified as either ExoS or ExoT. Given that ExoS and ExoT share 74% amino acid sequence homology, many of the peptide sequences retrieved
following trypsin digestion are almost identical. In these circumstances, ExoS and ExoT cannot be distinguished from each other.
b1 and2 arrows indicate whether the spot was more or less abundant in the PAO1 secretome than in the mep72 mutant secretome.
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our subsequent analyses on ExoS. ExoS displayed decreased ap-
parent stability in the mep72 mutant secretome, as evidenced by
the appearance ofmultiple lower-molecular-weight bands.Unlike
ExoS, which was found only in the culture supernatant, PcrV was
identified by Western analyses in the culture supernatant and in
the matrix surrounding the biofilm cells. In both of these frac-
tions, PcrV migrated as a single band in the mep72 mutant but
with a lower apparent molecular weight. These data indicate that,
contrary to expectation,Mep72 protects these targets against pro-
teolytic processing/degradation.
Mep72 and T3SS factors interact in vitro. A pulldown exper-
iment was conducted to determine if there was any physical inter-
action between Mep72 and the T3SS proteins. MBP-Mep72 was
overexpressed in E. coli, refolded in vitro, and then immobilized
on an amylose affinitymatrix. Secreted proteins froma stationary-
phase culture of PAO1 were allowed to bind, and the matrix was
washed. Bound proteins were eluted, separated by SDS-PAGE,
andprobed by immunoblot analysis with antibodies raised against
PcrV or ExoS (Fig. 7B). PcrV and ExoS coeluted with MBP-
Mep72, suggesting a direct physical interaction between these
proteins. As noted previously, since Mep72 was necessarily re-
folded in vitro for this experiment, these results are likely to un-
derrepresent the interaction(s) occurring in vivo.
DISCUSSION
In the current study, we used global proteomic analysis to directly
compare the secretome of biofilms and planktonic cell cultures.
Through this analysis, we identified a novel metzincin protease
(Mep72) whose expression appears to be highly biofilm specific
under these growth conditions. Further characterization of Mep72
revealed that it is secreted through the main terminal branch of the
type II general secretory pathway (Xcp system) and is processed dur-
ing (or possibly shortly after) export. We also found that in the ab-
sence of coexpressed bamI, heterologousmep72 expression is toxic to
E. coli, and that Mep72 and BamI form a protein-protein complex.
mep72 expression in biofilms was found to alter the electrophoretic
mobility of a discrete subset of secreted proteins, especially those as-
sociatedwithT3S.Mep72 subsequentlywas shown to physically cap-
ture PcrV and ExoS in vitro.
Recently, Balyimez et al. presented a preliminary report show-
ing that in wild-type PAO1, the PA2782-PA2783 genes are under
the control of the CRP homologue Vfr (34). However, their stud-
ies were carried out using planktonic cultures, where PA2783 ex-
pression is, in our hands, very low. Consistent with this, when they
examined the expression of PA2783 in the UWGC mutant bank
strain, lacZbp02q4E12 (which encodes a lacZ fusion at position 28
of the ORF, the same PA2783 mutant that we used in the current
study), Balyimez et al. found that-galactosidase activity was neg-
ligible unless vfr levels were artificially elevated by expression from
a high-copy-number plasmid (34). Similarly, alkaline phospha-
tase activity in cultures of PAO1 containing a plasmid-borne
PA2783::phoA fusion also was extremely low. Balyimez et al. also
found that when PA2783 is expressed in E. coli, the culture pro-
duces a zone of clearing when spotted onto skim-milk (protease)
bioassay plates. However, we find this difficult to reconcile with
the fact that E. coli lacks the main terminal branch of the general
secretory pathway and lacks any mechanism by which to secrete
proteases into the extracellular milieu. Instead, and given our re-
sults showing that the expression of PA2783 is toxic to E. coli, we
suspect that the zone of clearing observed by these workers arose
due to the release of intracellular proteases as a result of autolysis.
Consistent with this, these workers failed to identify any secreted
protease activity in concentrated supernatants from E. coli cul-
tures overexpressing PA2783, although they did identify a low
level of protease activity associated with the outermembrane frac-
tion. Based on these findings, Balyimez et al. concluded that
PA2783 is a membrane-bound 65-kDa endopeptidase and named
it Mep72 (34). Our data suggest that Mep72 is in fact a truly se-
creted protein and that it exhibits minimal endopeptidase activity
on generic substrates, such asmilk protein. Furthermore, the pro-
tein undergoes autoprocessing during export to yield a ca. 25-kDa
mature protein.
As with many other metzincins, we found that Mep72 under-
goes extensive processing before yielding the mature extracellular
form. In this regard,Mep72 shares similar genomic and biochem-
ical properties with its siblingmetzincin, AprA. Like AprA,Mep72
is coexpressed with an inhibitor protein, BamI, which presumably
suppresses the toxic activity of the metzincin until the latter has
been secreted (49, 50). However, unlike AprI (the inhibitor of
AprA), which has a well-defined tertiary structure, BamI contains
several regions that are predicted to be natively unfolded (data not
shown). Moreover, although AprA has been shown to cleave ge-
neric protein substrates, such as gelatin and casein (52), we found
no evidence thatMep72 is proteolytically active against these. The
twometzincins also differ in their mode of export; while AprA has
its own dedicated type I secretion system, Mep72 is secreted
through the Xcp-encoded type II secretion pathway.
Only a small number of proteins in the mep72 mutant secre-
tome displayed altered mobility on 2D gels, but these included
components of the T3S andmotility apparatus. It has not escaped
our notice that the T3S and flagellar apparatus are evolutionarily
related and that the proteins which pass through these assem-
FIG 7 Mep72 binds to T3S factors and prevents proteolytic processing. (A)
Western blot analysis of ExoS and PcrV secreted from 1-day-old PAO1 and
mep72 mutant biofilms. The ExoS-containing sample was concentrated cul-
ture supernatant (SN). The PcrV-containing samples are from culture super-
natant (SN) and cell-free biofilm matrix (BM), as indicated. Note the clear
difference in size of PcrV between the wild-type and mep72 mutant in both
sample types. (B) Western blot analysis of pulldown between Mep72 and T3S
factors ExoS and PcrV. Planktonic PAO1 culture supernatants (PAO1 super-
natant) were passed through an amylose column with or without prebound
MBP-Mep72 and eluted in 10 mM maltose. Lane 1, eluate from column pre-
charged with MBP-Mep72 after adding 10 mM maltose; lane 2, eluate from
control column after adding 10 mM maltose.
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blages are among the few secreted proteins which bypass the
periplasm completely during export. One interesting, albeit spec-
ulative, possibility is that as they pass through the periplasm,most
P. aeruginosa secreted proteins becomemodified in someway that
protects them from the action of potent (and in many cases, rela-
tively nonspecific) cosecreted proteases, such as LasB. From an
anthropocentric viewpoint, without such a mechanism, it may be
counterproductive to secrete exoproteins into a preexisting, self-
made proteolytic soup. Such protective posttranslational modifi-
cationsmay account for the “charge trains” commonly seen in 2D
gels of P. aeruginosa secretome samples, a possibility that we are
currently investigating. Presumably, given that the T3S and flagel-
lar proteins bypass the periplasm, they do not receive any such
protective modification. This may explain why these proteins in
particular are targeted by Mep72, which, counterintuitively, ap-
pears to protect T3S proteins (PcrV and ExoS) from proteolysis
(Fig. 7A). HowMep72 recognizes its target proteins is not known.
Presumably, Mep72 recognizes specific sequence motifs in these
targets. Alternatively, it may be that the absence of a protective
periplasm-conferred modification (that is normally present on
other secreted proteins) promotes Mep72 binding. Posttransla-
tional modification of extracellular proteins is not in itself un-
usual; as noted by Nouwens and colleagues, a plethora of secreted
proteins undergo posttranslational modification in P. aeruginosa,
leading to the formation of multiple distinct spots of the same
protein on 2D gels (27). Indeed, LasB is represented by as many as
11 discrete spots (or processed isoforms), and the LasA protease is
known to be processed by other secreted endopeptidases, includ-
ing LasB (53, 54). It is possible that Mep72 contributes to this
complex network of processing by protecting its substrates from
proteolysis by other secreted proteases.
Mep72 was shown to influence the electrophoretic mobility of
a number of structural components of the T3SS translocation
complex (PcrV and PopD). Here, we demonstrate a physical in-
teraction betweenMep72 and PcrV by an in vitro pulldown assay.
However, it remains unclear whether Mep72 associates with as-
sembled but surface-detached (broken) needle complexes or
whether PcrV and PopD are truly secreted proteins. This is still an
area of active research; for example, a study by Akopyan and col-
leagues demonstrated that translocators and effectors of the Yer-
sinia T3SS localized to the surface of bacterial cells before target
cell contact (55).
Purified Mep72 underwent rapid and essentially complete au-
todigestion following refolding in vitro. This feature may be phys-
iologically relevant (e.g., serving to self-limit the accumulation of
the protein in culture supernatants), or it may be an artifact of the
refolding procedure; loosely folded or partially folded intermedi-
ates may be more susceptible to proteolysis by small amounts of
correctly folded protease. One possible missing refolding factor
was zinc ions. However, the addition of supplementary zinc to
the refolding buffer had no impact on the autolytic kinetics of the
refolded His6-tagged protein (data not shown). Another possible
refolding factor is BamI. This protein clearly confers protection
upon cells expressing Mep72 (Fig. 5A), although its precise mode
of action is uncertain. It remains unclear whether this protein
simply binds to Mep72 and inhibits its protease activity (as in the
AprI-AprA interaction) or whether this binding simply prevents
Mep72 from recognizing its target proteins. These are open ques-
tions that we are currently investigating further.
Curiously, a nucleotide substitution that led to the intro-
duction of a stop codon 5= of the carbohydrate-binding do-
mains obviated toxicity, as revealed by a bypass screen. Addi-
tionally, expression of neither the metzincin domain nor
carbohydrate-binding domains alone resulted in toxicity. This
suggests that all 3 domains must be present for toxicity to be
manifest. One possibility is that all three domains are required
for proper folding of the protein.
In summary, we have demonstrated that the secretome of
planktonic cell cultures is very different from that of biofilms. This
work led to the discovery and subsequent characterization of
Mep72, a novel metzincin. Current work is aimed at better under-
standing the precise mechanism by which Mep72 affects the T3S
proteins and the biochemical consequences of this processing.We
are also investigating what regulates bamI-mep72 expression in
biofilms.
ACKNOWLEDGMENTS
This study was funded by the BBSRC, the Isaac Newton Trust (Cam-
bridge), and a grant from the Japanese Society for Acute Infection to K.N.
We thank Helga Mikkelsen for help with the preliminary proteomic
analyses.
REFERENCES
1. Lam J, Chan R, Lam K, Costerton JW. 1980. Production of mucoid
microcolonies by Pseudomonas aeruginosa within infected lungs in cystic
fibrosis. Infect Immun 28:546–556.
2. Govan JR, Deretic V. 1996. Microbial pathogenesis in cystic fibrosis:
mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol
Rev 60:539–574.
3. Costerton JW, Stewart PS, Greenberg EP. 1999. Bacterial biofilms: a
common cause of persistent infections. Science 284:1318–1322. http://dx
.doi.org/10.1126/science.284.5418.1318.
4. Singh PK, Schaefer AL, Parsek MR, Moninger TO, Welsh MJ, Green-
berg EP. 2000. Quorum-sensing signals indicate that cystic fibrosis lungs
are infectedwith bacterial biofilms.Nature 407:762–764. http://dx.doi.org
/10.1038/35037627.
5. Lewis K. 2001. Riddle of biofilm resistance. Antimicrob Agents Chemother
45:999–1007. http://dx.doi.org/10.1128/AAC.45.4.999-1007.2001.
6. Parsek MR, Singh PK. 2003. Bacterial biofilms: an emerging link to
disease pathogenesis. Annu Rev Microbiol 57:677–701. http://dx.doi.org
/10.1146/annurev.micro.57.030502.090720.
7. Whiteley M, Bangera MG, Bumgarner RE, Parsek MR, Teitzel GM,
Lory S, Greenberg EP. 2001. Gene expression in Pseudomonas aerugi-
nosa biofilms. Nature 413:860–864. http://dx.doi.org/10.1038/35101627.
8. Sauer K, Camper AK, Ehrlich GD, Costerton JW, Davies DG. 2002.
Pseudomonas aeruginosa displays multiple phenotypes during develop-
ment as a biofilm. J Bacteriol 184:1140–1154. http://dx.doi.org/10.1128
/jb.184.4.1140-1154.2002.
9. Hentzer M, Eberl L, Givskov M. 2005. Transcriptome analysis of
Pseudomonas aeruginosa biofilm development: anaerobic respiration
and iron limitation. Biofilms 2:37–61. http://dx.doi.org/10.1017/S147
9050505001699.
10. Waite RD, Papakonstantinopoulou A, Littler E, Curtis MA. 2005.
Transcriptome analysis of Pseudomonas aeruginosa growth: comparison
of gene expression in planktonic cultures and developing andmature bio-
films. J Bacteriol 187:6571–6576. http://dx.doi.org/10.1128/JB.187.18
.6571-6576.2005.
11. Mikkelsen H, Bond NJ, Skindersoe ME, Givskov M, Lilley KS, Welch
M. 2009. Biofilms and type III secretion are not mutually exclusive in
Pseudomonas aeruginosa. Microbiology 155:687–698. http://dx.doi.org
/10.1099/mic.0.025551-0.
12. Dötsch A, Eckweiler D, Schniederjans M, Zimmermann A, Jensen V,
Scharfe M, Geffers R, Häussler S. 2012. The Pseudomonas aeruginosa
transcriptome in planktonic cultures and static biofilms using RNA se-
quencing. PLoS One 7:e31092. http://dx.doi.org/10.1371/journal.pone
.0031092.
13. Patell S, Gu M, Davenport P, Givskov M, Waite RD, Welch M. 2010.
Comparative microarray analysis reveals that the core biofilm-
Protease Expressed in Bioﬁlms
February 2015 Volume 197 Number 4 jb.asm.org 771Journal of Bacteriology
 o
n
 February 16, 2015 by M
RC LAB O
F M
O
LECULAR BIO
LO
G
Y
http://jb.asm.org/
D
ow
nloaded from
 
associated transcriptome of Pseudomonas aeruginosa comprises rela-
tively few genes. Environ Microbiol Rep 2:440–448. http://dx.doi.org
/10.1111/j.1758-2229.2010.00158.x.
14. Van Delden C, Iglewski BH. 1998. Cell-to-cell signaling and Pseudomo-
nas aeruginosa infections. Emerg Infect Dis 4:551–560. http://dx.doi.org
/10.3201/eid0404.980405.
15. Bleves S, Viarre V, Salacha R, Michel GPF, Filloux A, Voulhoux R.
2010. Protein secretion systems in Pseudomonas aeruginosa: a wealth of
pathogenic weapons. Int J MedMicrobiol 300:534–543. http://dx.doi.org
/10.1016/j.ijmm.2010.08.005.
16. Yahr TL, Goranson J, Frank DW. 1996. Exoenzyme S of Pseudomonas
aeruginosa is secreted by a type III pathway. Mol Microbiol 22:991–1003.
http://dx.doi.org/10.1046/j.1365-2958.1996.01554.x.
17. Yahr TL, Mende-Mueller LM, Friese MB, Frank DW. 1997. Identifica-
tion of type III secreted products of the Pseudomonas aeruginosa exoen-
zyme S regulon. J Bacteriol 179:7165–7168.
18. Hauser AR, Cobb E, Bodi M, Mariscal D, Vallés J, Engel JN, Rello J.
2002. Type III protein secretion is associated with poor clinical out-
comes in patients with ventilator-associated pneumonia caused by
Pseudomonas aeruginosa. Crit Care Med 30:521–528. http://dx.doi
.org/10.1097/00003246-200203000-00005.
19. Roy-Burman A, Savel RH, Racine S, Swanson BL, Revadigar NS, Fu-
jimoto J, Sawa T, Frank DW, Wiener-Kronish JP. 2001. Type III protein
secretion is associated with death in lower respiratory and systemic Pseu-
domonas aeruginosa infections. J Infect Dis 183:1767–1774. http://dx.doi
.org/10.1086/320737.
20. Goodman AL, Kulasekara B, Rietsch A, Boyd D, Smith RS, Lory S.
2004. A signaling network reciprocally regulates genes associated with
acute infection and chronic persistence in Pseudomonas aeruginosa. Dev
Cell 7:745–754. http://dx.doi.org/10.1016/j.devcel.2004.08.020.
21. Ventre I, Goodman AL, Vallet-Gely I, Vasseur P, Soscia C, Molin S,
Bleves S, Lazdunski A, Lory S, Filloux A. 2006. Multiple sensors control
reciprocal expression of Pseudomonas aeruginosa regulatory RNA and
virulence genes. Proc Natl Acad Sci U S A 103:171–176. http://dx.doi.org
/10.1073/pnas.0507407103.
22. Furukawa S, Kuchma SL, O’Toole GA. 2006. Keeping their options open:
acute versus persistent infections. J Bacteriol 188:1211–1217. http://dx.doi
.org/10.1128/JB.188.4.1211-1217.2006.
23. Schaber JA, Triffo WJ, Suh SJ, Oliver JW, Hastert MC, Griswold JA,
Auer M, Hamood AN, Rumbaugh KP. 2007. Pseudomonas aerugi-
nosa forms biofilms in acute infection independent of cell-to-cell sig-
naling. Infect Immun 75:3715–3721. http://dx.doi.org/10.1128/IAI
.00586-07.
24. Yang L, Haagensen JAJ, Jelsbak L, Johansen HK, Sternberg C, Høiby N,
Molin S. 2008. In situ growth rates and biofilm development of Pseu-
domonas aeruginosa populations in chronic lung infections. J Bacteriol
190:2767–2776. http://dx.doi.org/10.1128/JB.01581-07.
25. Horsman SR, Moore RA, Lewenza S. 2012. Calcium chelation by
alginate activates the type III secretion system inmucoid Pseudomonas
aeruginosa biofilms. PLoS One 7:e46826. http://dx.doi.org/10.1371
/journal.pone.0046826.
26. Arevalo-Ferro C, Hentzer M, Reil G, Görg A, Kjelleberg S, Givskov M,
Riedel K, Eberl L. 2003. Identification of quorum-sensing regulated pro-
teins in the opportunistic pathogen Pseudomonas aeruginosa by pro-
teomics. Environ Microbiol 5:1350–1369. http://dx.doi.org/10.1046/j
.1462-2920.2003.00532.x.
27. Nouwens AS, Beatson SA, Whitchurch CB, Walsh BJ, Schweizer HP,
Mattick JS, Cordwell SJ. 2003. Proteome analysis of extracellular proteins
regulated by the las and rhl quorum sensing systems in Pseudomonas
aeruginosa PAO1. Microbiology 149:1311–1322. http://dx.doi.org/10
.1099/mic.0.25967-0.
28. Kim E-J, Wang W, Deckwer W-D, Zeng A-P. 2005. Expression of the
quorum-sensing regulatory protein LasR is strongly affected by iron and
oxygen concentrations in cultures of Pseudomonas aeruginosa irrespec-
tive of cell density. Microbiology 151:1127–1138. http://dx.doi.org/10
.1099/mic.0.27566-0.
29. Nalca Y, Jänsch L, Bredenbruch F, Geffers R, Buer J, Häussler S.
2006. Quorum-sensing antagonistic activities of azithromycin in Pseu-
domonas aeruginosa PAO1: a global approach. Antimicrob Agents
Chemother 50:1680–1688. http://dx.doi.org/10.1128/AAC.50.5.1680
-1688.2006.
30. Toyofuku M, Roschitzki B, Riedel K, Eberl L. 2012. Identification of
proteins associated with the Pseudomonas aeruginosa biofilm extra-
cellular matrix. J Proteome Res 11:4906–4915. http://dx.doi.org/10
.1021/pr300395j.
31. Sarkisova S, Patrauchan MA, Berglund D, Nivens DE, Franklin MJ.
2005. Calcium-induced virulence factors associated with the extracellular
matrix of mucoid Pseudomonas aeruginosa biofilms. J Bacteriol 187:
4327–4337. http://dx.doi.org/10.1128/JB.187.13.4327-4337.2005.
32. Purschke FG, Hiller E, Trick I, Rupp S. 2012. Flexible survival strategies
of Pseudomonas aeruginosa in biofilms result in increased fitness com-
pared with Candida albicans. Mol Cell Proteomics 11:1652–1669. http:
//dx.doi.org/10.1074/mcp.M112.017673.
33. Borlee BR, Goldman AD, Murakami K, Samudrala R, Wozniak DJ,
Parsek MR. 2010. Pseudomonas aeruginosa uses a cyclic-di-GMP-
regulated adhesin to reinforce the biofilm extracellular matrix. Mol Mi-
crobiol 75:827–842. http://dx.doi.org/10.1111/j.1365-2958.2009.06991.x.
34. Balyimez A, Colmer-Hamood JA, Francisco MS, Hamood AN. 2013.
Characterization of the Pseudomonas aeruginosa metalloendopeptidase,
Mep72, a member of the Vfr regulon. BMC Microbiol 13:269. http://dx
.doi.org/10.1186/1471-2180-13-269.
35. Mikkelsen H, Duck Z, Lilley KS, Welch M. 2007. Interrelationships
between colonies, biofilms, and planktonic cells of Pseudomonas aerugi-
nosa. J Bacteriol 189:2411–2416. http://dx.doi.org/10.1128/JB.01687-06.
36. Kwon DH, Lu C-D. 2006. Polyamines induce resistance to cationic pep-
tide, aminoglycoside, and quinolone antibiotics in Pseudomonas aerugi-
nosa PAO1. Antimicrob Agents Chemother 50:1615–1622. http://dx.doi
.org/10.1128/AAC.50.5.1615-1622.2006.
37. Kwon DH, Lu C-D. 2006. Polyamines increase antibiotic susceptibility in
Pseudomonas aeruginosa. Antimicrob Agents Chemother 50:1623–1627.
http://dx.doi.org/10.1128/AAC.50.5.1623-1627.2006.
38. Kwon D-H, Lu C-D. 2007. Polyamine effects on antibiotic susceptibility
in bacteria. Antimicrob Agents Chemother 51:2070–2077. http://dx.doi
.org/10.1128/AAC.01472-06.
39. Wilderman PJ, Vasil AI, Johnson Z, Wilson MJ, Cunliffe HE, Lamont
IL, Vasil ML. 2001. Characterization of an endoprotease (PrpL) encoded
by a PvdS-regulated gene in Pseudomonas aeruginosa. Infect Immun 69:
5385–5394. http://dx.doi.org/10.1128/IAI.69.9.5385-5394.2001.
40. Folders J, Tommassen J, van Loon LC, Bitter W. 2000. Identification of
a chitin-binding protein secreted by Pseudomonas aeruginosa. J Bacteriol
182:1257–1263. http://dx.doi.org/10.1128/JB.182.5.1257-1263.2000.
41. Mao F, Dam P, Chou J, Olman V, Xu Y. 2009. DOOR: a database for
prokaryotic operons. Nucleic Acids Res 37:D459–D463. http://dx.doi.org
/10.1093/nar/gkn757.
42. Murzin AG. 1992. Structural principles for the propeller assembly of
beta-sheets: the preference for seven-fold symmetry. Proteins 14:191–201.
http://dx.doi.org/10.1002/prot.340140206.
43. Yeats C, Bentley S, Bateman A. 2003. New knowledge from old: in silico
discovery of novel protein domains in Streptomyces coelicolor. BMCMi-
crobiol 3:3. http://dx.doi.org/10.1186/1471-2180-3-3.
44. Shi J, Blundell TL, Mizuguchi K. 2001. FUGUE: sequence-structure
homology recognition using environment-specific substitution tables and
structure-dependent gap penalties. J Mol Biol 310:243–257. http://dx.doi
.org/10.1006/jmbi.2001.4762.
45. Bode W, Grams F, Reinemer P, Gomis-Rüth FX, Baumann U,
McKay DB, Stöcker W. 1996. The metzincin-superfamily of zinc-
peptidases. Adv ExpMed Biol 389:1–11. http://dx.doi.org/10.1007/978
-1-4613-0335-0_1.
46. Gomis-Rüth FX. 2003. Structural aspects of the metzincin clan of met-
alloendopeptidases. Mol Biotechnol 24:157–202. http://dx.doi.org/10
.1385/MB:24:2:157.
47. Gilkes NR, Henrissat B, Kilburn DG, Miller RC, Warren RA. 1991.
Domains in microbial beta-1,4-glycanases: sequence conservation, func-
tion, and enzyme families. Microbiol Rev 55:303–315.
48. Ball G, Chapon-Hervé V, Bleves S, Michel G, Bally M. 1999. Assembly
of XcpR in the cytoplasmicmembrane is required for extracellular protein
secretion in Pseudomonas aeruginosa. J Bacteriol 181:382–388.
49. Feltzer RE, Gray RD, Dean WL, Pierce WM. 2000. Alkaline protein-
ase inhibitor of Pseudomonas aeruginosa. Interaction of native and
N-terminally truncated inhibitor proteins with Pseudomonas metallo-
proteinases. J Biol Chem 275:21002–21009. http://dx.doi.org/10.1074
/jbc.M002088200.
50. Hege T, Feltzer RE, Gray RD, Baumann U. 2001. Crystal structure of a
complex between Pseudomonas aeruginosa alkaline protease and its cog-
nate inhibitor: inhibition by a zinc-NH2 coordinative bond. J Biol Chem
276:35087–35092. http://dx.doi.org/10.1074/jbc.M104020200.
Passmore et al.
772 jb.asm.org February 2015 Volume 197 Number 4Journal of Bacteriology
 o
n
 February 16, 2015 by M
RC LAB O
F M
O
LECULAR BIO
LO
G
Y
http://jb.asm.org/
D
ow
nloaded from
 
51. Bardoel BW, van Kessel KPM, van Strijp JAG, Milder FJ. 2012. Inhi-
bition of Pseudomonas aeruginosa virulence: characterization of the
AprA-AprI interface and species selectivity. J Mol Biol 415:573–583. http:
//dx.doi.org/10.1016/j.jmb.2011.11.039.
52. Caballero AR, Moreau JM, Engel LS, Marquart ME, Hill JM,
O’Callaghan RJ. 2001. Pseudomonas aeruginosa protease IV enzyme as-
says and comparison to other Pseudomonas proteases. Anal Biochem 290:
330–337. http://dx.doi.org/10.1006/abio.2001.4999.
53. Kessler E, Safrin M, Gustin JK, Ohman DE. 1998. Elastase and the LasA
protease of Pseudomonas aeruginosa are secreted with their propeptides. J
Biol Chem 273:30225–30231. http://dx.doi.org/10.1074/jbc.273.46.30225.
54. Braun P, de Groot A, Bitter W, Tommassen J. 1998. Secretion of
elastinolytic enzymes and their propeptides by Pseudomonas aeruginosa.
J Bacteriol 180:3467–3469.
55. Akopyan K, Edgren T, Wang-Edgren H, Rosqvist R, Fahlgren A, Wolf-
Watz H, Fallman M. 2011. Translocation of surface-localized effectors in
type III secretion. Proc Natl Acad Sci U S A 108:1639–1644. http://dx.doi
.org/10.1073/pnas.1013888108.
Protease Expressed in Bioﬁlms
February 2015 Volume 197 Number 4 jb.asm.org 773Journal of Bacteriology
 o
n
 February 16, 2015 by M
RC LAB O
F M
O
LECULAR BIO
LO
G
Y
http://jb.asm.org/
D
ow
nloaded from
 
